Search Follow us

The Biotech Growth Trust (BIOG)

Business description

The Biotech Growth Trust seeks capital appreciation through investing in the worldwide biotechnology industry, mainly in emerging biotechnology companies. Performance is measured against its benchmark index, the NASDAQ Biotechnology Index (sterling adjusted).

Stock data

Market cap.£371.5m
Last close696.00p
High / Low (52 weeks)849.0p / 650.0p
Stock market listingLN
Forecast net debt (m)N/A
Forecast gearing ratio (%)N/A
TeamInvestment Companies
SectorInvestment Companies

Other companies in sector Show

Aberdeen Asian Income Fund Aberdeen New Dawn Investment Trust
Aberdeen New Thai Investment Trust Aberdeen Private Equity Fund
Aberdeen Standard Equity Income Trust Aberdeen UK Tracker Trust
AcenciA Debt Strategies Acorn Income Fund
Adamas Finance Asia Alliance Trust
Altamir SCA Amphion Innovations
Atlantis Japan Growth Fund Aurelius
Bailador Tech Investments Baker Steel Resources Trust
Bankers Investment Trust (The) BB Biotech
BioPharma Credit BlackRock Emerging Europe
BlackRock Greater Europe Investment Trust BlackRock Hedge Selector
BlackRock Latin American Inv. Trust BMO Managed Portfolio Trust Growth Portfolio
BMO Managed Portfolio Trust Income Portfolio British Portfolio Trust
Brunner Investment Trust (The) Canadian General Investments
Carador Income Fund CFP Sanford DeLand Free Spirit Fund.
Charles Stanley City Natural Resources
Conversus Capital CQS Rig Finance Fund
CVC Credit Partners European Opps Detour Gold
Deutsche Beteiligungs Dexion Commodities
Diverse Income Trust (The) DouglasBay Capital
Dunedin Enterprise Investment Trust DW Catalyst Fund
Edinburgh Worldwide Investment Trust (The) EJF Investments
European Assets Trust European Investment Trust (The)
F&C Investment Trust F&C US Smaller Companies
Fidelity Asian Values Fidelity China Special Situations
Fidelity European Values Fidelity Japan Trust
Fidelity Special Values Finsbury Growth & Income Trust
Gartmore Growth Opportunities Gartmore Irish Growth Fund
Geiger Counter Limited Genesis Emerging Markets Fund
GLI Alternative Finance Global Resources Investment Trust
Golden Prospect Precious Metals Gulf Investment Fund
Hansa Trust (HAN) HarbourVest Global Private Equity
HarbourVest Senior Loans Europe HBM Healthcare Investments
Heliad Equity Partners Henderson Alternative Strategies Trust
Henderson Far East Income Henderson Global Trust
Henderson Global Trust Henderson International Income Trust
Heptagon HSBC Infrastructure Company
Infrastructure India International Biotechnology Trust
Invesco Asia Trust Invesco Income Growth Trust
Is Private Equity JP Morgan Private Equity Limited
JPMorgan Brazil Investment Trust JPMorgan European Smaller Companies Trust
JPMorgan Global Convertibles Income Fund JPMorgan Global Growth & Income
JPMorgan Indian Investment Trust Jupiter Green Investment Trust
Jupiter UK Growth Investment Trust Jupiter US Smaller Companies
JZ Capital Partners Limited Lazard World Trust Fund
Leaf Clean Energy Company LMS Capital
Lowland Investment Company LPeC
Marble Point Loan Financing Martin Currie Asia Unconstrained Trust
Martin Currie Global Portfolio Trust Middlefield Canadian Income
Miton Global Opportunities Miton Income Opportunities Trust
Murray International Trust New City Energy
Ocean Wilsons Holdings Odyssean Investment Trust
Pacific Assets Trust Phaunos Timber Fund
Polar Capital Global Healthcare Trust Princess Private Equity Holding
PXP Vietnam Fund Rathbone Brothers
RENN Universal Growth Investment Trust Schroder AsiaPacific Fund
Schroder Global Real Estate Securities ScotGems
Scottish Oriental Smaller Companies Securities Trust of Scotland
Seneca Global Income & Growth Trust Sigma Capital Group
Standard Life Investments Property Income Trust Standard Life Private Equity Trust
Standard Life UK Smaller Companies Strategic Equity Capital
Taiwan Fund (The) Templeton Emerging Markets Investment Trust
Tetragon Financial Group The Global Sustainability Trust
The Law Debenture Corporation The Merchants Trust
The North American Income Trust The Scottish Investment Trust
Tiso Blackstar Group Toscafund Asset Management
TR European Growth Trust UK Commercial Property REIT
Utilico Emerging Markets Trust Vietnam Enterprise Investments
Vietnam Holding Asset Management Vietnam Infrastructure Fund
VinaCapital Vietnam Opportunity Fund VinaLand
Vision Opportunity China Fund Volta Finance
WAM Active WAM Capital
WAM Research Witan Investment Trust
Witan Pacific Investment Trust Worldwide Healthcare Trust
YFM Equity Partners

Company news

Investment summary

The Biotech Growth Trust (BIOG) is managed by Geoff Hsu and Richard Klemm of OrbiMed Capital. They aim to generate long-term capital growth from a diversified portfolio of global biotech equities. The managers are very optimistic on the industry outlook, citing a more benign political environment, a high level of innovation, a favourable regulatory regime, and reasonable valuations. In addition, following US tax reform, they expect an acceleration in merger and acquisition activity, which has historically been an important driver of share prices within the biotech sector. The managers acknowledge that BIOG’s performance in the last three financial years has been disappointing and they are looking to build on the trust’s long-term record of outperformance versus the benchmark NASDAQ Biotechnology index.

Last updated on 30/07/2018

Key management

Andrew Joy, Chairman
Richard Klemm, Fund manager
Geoffrey Hsu, Fund manager

Company address

One Wood Street
London
EC2V 7WS
United Kingdom
View website